Filana Therapeutics plans Simufilam Phase 2a screening by Q1 2027
Filana Therapeutics plans to begin patient screening for its Simufilam Phase 2a study by the first quarter of 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.